Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of General Internal Medicine
Published in: Journal of General Internal Medicine 3/2011

01-03-2011 | Clinical Practice: Clinical Vignettes

Mycobacterium Porcinum Peritonitis in a Patient on Continuous Ambulatory Peritoneal Dialysis

Authors: Ritesh Patil, MD, MPH, Trupti Patil, MD, MPH, Louis Schenfeld, MD, Samuel Massoud, MD

Published in: Journal of General Internal Medicine | Issue 3/2011

Login to get access

Abstract

Mycobacterium porcinum has been reported to cause a variety of illnesses including wound infections, respiratory tract infections, osteomyelitis and catheter-related bacteremias. We report the first case of M. porcinum peritonitis in a patient on continuous ambulatory peritoneal dialysis (CAPD). A 67-year-old woman on CAPD presented with three weeks of constitutional symptoms and abdominal pain. Peritoneal fluid cultures on day three grew acid-fast rods. Nocardiosis was suspected and the patient was empirically treated with amikacin and trimethoprim-sulfamethoxazole. The dialysis catheter was removed. Two weeks later final culture results revealed M. porcinum. Ciprofloxacin and trimethoprim-sulfamethoxazole were initiated with good clinical response.
Literature
1.
Wong HS, Ong LM, Lim TO, et al. A randomized, multicenter, open-label trial to determine peritonitis rate, product defect, and technique survival between ANDY-Disc and UltraBag in patients on CAPD. Am J Kidney Dis. 2006;48(3):464–472.CrossRefPubMed
2.
Malti J, Wellons D. CAPD: a dialysis breakthrough with its own burdens. RN. 1988;51(1):46–52.PubMed
3.
Saklayen MG. CAPD peritonitis. Incidence, pathogens, diagnosis, and management. Med Clin North Am. 1990;74(4):997–1010.PubMed
4.
Dalaman G, Haklar G, Sipahiu A, Ozener C, Akoĝlu E, Yalçin AS. Early detection of peritonitis in continuous ambulatory peritoneal dialysis patients by use of chemiluminescence: evaluation of diagnostic accuracy by receiver-operating characteristic curve analysis. Clin Chem. 1998;44(8 Pt 1):1680–4.PubMed
5.
Novak DJ, Bashir K, Baltaro RJ, et al. Neisseria sicca/subflava: continuous ambulatory peritoneal dialysis-associated peritonitis. Lab Med. 2007;38(6):363–4.CrossRef
6.
Huang JW, Hung KY, Yen CJ, Wu KD, Tsai TJ. Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis. Nephrol Dial Transplant. 2001;16(3):604–7.CrossRefPubMed
7.
Paul E, Devarajan P. Mycobacterium phlei peritonitis: a rare complication of chronic peritoneal dialysis. Pediatr Nephrol. 1998;12(1):67–8.CrossRefPubMed
8.
Nolph KD, Cutler SJ, Steinberg SM, Novak JW. Continuous ambulatory peritoneal dialysis in the United States: a three-year study. Kidney Int. 1985;28(2):198–205.CrossRefPubMed
9.
Fried LF, Bernardini J, Johnston JR, Piraino B. Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol. 1996;7(10):2176–82.PubMed
10.
Port FK, Held PJ, Nolph KD, Turenne MN, Wolfe RA. Risk of peritonitis and technique failure by CAPD connection technique: a national study. Kidney Int. 1992;42(4):967–74.CrossRefPubMed
11.
Elcuaz’ R, Baamondef E, Campos-Herrero MI, Lafarga B. Peritonitis in a patient undergoing peritoneal dialysis caused by Mycobacterium abscessus. Antimicrob Infect Dis Newsl. 1996;15(8):54–5.CrossRef
12.
Hakim A, Hisam N, Reuman PD. Environmental mycobacterial peritonitis complicating peritoneal dialysis: three cases and review. Clin Infect Dis. 1993;16(3):426–31.PubMed
13.
Hevia C, Bajo A, Sanchez-Tomero A, et al. Peritoneal catheter exit site infections caused by rapidly-growing atypical mycobacteria. Nephrol Dial Transplant. 2000;15:1458–60.CrossRefPubMed
14.
Paul E, Devarajan P. Mycobacterium phlei peritonitis: a rare complication of chronic peritoneal dialysis. Pediatr Nephrol. 1998;12(1):67–8.CrossRefPubMed
15.
Wallace RJ, Brown-Elliott BA, Wilson RW, et al. Clinical and laboratory features of Mycobacterium porcinum. J Clin Microbiol. 2004;42(12):5689–9742.CrossRefPubMed
16.
Piraino B, Bailie GR, Bernardini J, et al. ISPD guidelines/recommendations. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25(2):107–131.PubMed
17.
Rho M, Bia F, Brewster UC. Nontuberculous mycobacterial peritonitis in peritoneal dialysis patients. Semin Dial. 2007;20(3):271–6.CrossRefPubMed
18.
Keenan N, Jeyaratnam D, Sheerin NS. Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis. Am J Kidney Dis. 2005;45(5):e75–e78.CrossRefPubMed
19.
Chu KH, Fung KS, Tsang WK, Chan HW, Tong KL. Nocardia peritonitis: satisfactory response to intraperitoneal trimethoprim-sulfamethoxazole. Perit Dial Int. 2003;23(2):197–8.PubMed
20.
Dwyer K, Daffy J, Murphy B. Nocardia peritonitis and abdominal abscess complicating continuous ambulatory peritoneal dialysis. Nephrol. 2001;6:263–5.CrossRef
21.
Tsukamura M, Nemoton H, Yugi H.Mycobacterium porcinum sp. nov., a porcine pathogen. Int J Syst Bacteriol. 1983;33:162–5.CrossRef
22.
Schinsky MF, Morey RE, Steigerwalt AG, et al. Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol. 2004;54(Pt 5):1653–67.CrossRefPubMed
23.
Idigoras P, Jiménez-Alfaro JA, Mendiola J. Postoperative sternal osteomyelitis due to Mycobacterium Porcinum. Enferm Infecc Microbiol Clín. 2007;25(1):68–9.PubMed
Metadata
Title
Mycobacterium Porcinum Peritonitis in a Patient on Continuous Ambulatory Peritoneal Dialysis
Authors
Ritesh Patil, MD, MPH
Trupti Patil, MD, MPH
Louis Schenfeld, MD
Samuel Massoud, MD
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 3/2011
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1571-y

Other articles of this Issue 3/2011

Journal of General Internal Medicine 3/2011 Go to the issue

Editorials

Hepatitis B—More Treatments, More Testing, Not Enough Data

Editorials

From the Editors’ Desk: Disparities Near and Far

Original Research

Validation of Self-Reported Health Literacy Questions Among Diverse English and Spanish-Speaking Populations

Original Research

Quality Concerns with Routine Alcohol Screening in VA Clinical Settings

Original Research

Alterations in Medical Interpretation During Routine Primary Care

Letters

Patient Care Outside of Office Visits
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits